US junior doctors found to be ignorant of drug companies' tactics

BMJ 2004; 328 doi: 10.1136/bmj.328.7447.1032-a (Published 29 April 2004)
Cite this as: BMJ 2004;328:1032.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Spurgeon
  1. Quebec

    Although drug companies spend billions of dollars on marketing their products and have been successful in influencing doctors' prescribing decisions, a new study shows that only a small proportion of medical residency programmes in the United States teach doctors how to deal with such pressures (Academic Medicine 2004;79: 432-7).

    Dr Raquel Watkins, lead author of the study and assistant professor of internal medicine at Wake Forest University Baptist Medical …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL